These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30325612)

  • 1. Changing bulking agent may require change in injection volume for endoscopic treatment of vesicoureteral reflux.
    Tekin A; Yagmur I; Tiryaki S; Dokumcu Z; Ulman I; Avanoglu A
    Int Braz J Urol; 2018; 44(6):1194-1199. PubMed ID: 30325612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison between dextranomer/ hyaluronic acid and polyacrylate polyalcohol copolymer as bulking agents for treating primary vesicoureteral reflux.
    Alizadeh F; Omidi I; Haghdani S; Hatef Khorrami M; Izadpanahi MH; Mohammadi Sichani M
    Urol J; 2019 May; 16(2):174-179. PubMed ID: 30178456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The outcomes of two different bulking agents (dextranomer hyaluronic acid copolymer and polyacrylate-polyalcohol copolymer) in the treatment of primary vesico-ureteral reflux.
    Taşkinlar H; Avlan D; Bahadir GB; Delibaş A; Nayci A
    Int Braz J Urol; 2016; 42(3):514-20. PubMed ID: 27286115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized clinical trial between polyacrylate-polyalcohol copolymer (PPC) and dextranomer-hyaluronic acid copolymer (Dx/HA) as bulking agents for endoscopic treatment of primary vesicoureteral reflux (VUR).
    García-Aparicio L; Blázquez-Gómez E; Martin O; Pérez-Bertólez S; Arboleda J; Soria A; Tarrado X
    World J Urol; 2018 Oct; 36(10):1651-1656. PubMed ID: 29725806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic treatment of grades IV and V vesicoureteral reflux with two bulking substances: Dextranomer hyaluronic acid copolymer versus polyacrylate polyalcohol copolymer in children.
    Kocaoglu C
    J Pediatr Surg; 2016 Oct; 51(10):1711-5. PubMed ID: 27117052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter?
    Dogan HS; Altan M; Citamak B; Bozaci AC; Koni A; Tekgul S
    J Pediatr Urol; 2015 Apr; 11(2):90.e1-5. PubMed ID: 25791422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of results of endoscopic correction of vesicoureteral reflux in children using two bulking substances: Dextranomer/hyaluronic acid copolymer (Deflux) versus polyacrylate-polyalcohol copolymer (Vantris).
    Warchol S; Krzemien G; Szmigielska A; Bombinski P; Brzewski M; Dudek-Warchol T
    J Pediatr Urol; 2016 Aug; 12(4):256.e1-4. PubMed ID: 27593921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextranomer-Hyaluronic Acid and Polyacrylate-Polyalcohol Copolymer are Equally Efficient for Endoscopic Treatment of Vesicoureteral Reflux in Children.
    Bele U; Bratus D
    Urol J; 2019 Aug; 16(4):361-365. PubMed ID: 30318569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What are the predictive factors leading to ureteral obstruction following endoscopic correction of VUR in the pediatric population?
    Chertin B; Mele E; Kocherov S; Zilber S; Gerocarni Nappo S; Capozza N
    J Pediatr Urol; 2018 Dec; 14(6):538.e1-538.e7. PubMed ID: 29885870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vantris vs. deflux for treatment of paediatric vesicoureteral reflux: Efficacy and obstruction risk.
    Renaux-Petel M; Grynberg L; Lubet A; Comte D; Liard-Zmuda A
    Fr J Urol; 2024 Mar; 34(2):102585. PubMed ID: 38717460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic injection of dextranomer hyaluronic acid copolymer for the treatment of vesicoureteral reflux in duplex ureters.
    Molitierno JA; Scherz HC; Kirsch AJ
    J Pediatr Urol; 2008 Oct; 4(5):372-6. PubMed ID: 18790423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the double hydrodistention implantation technique (HIT) and the HIT with a polyacrylate/polyalcohol copolymer (PPC) for the endoscopic treatment of primary vesicoureteral reflux.
    Akin M; Erginel B; Karadag CA; Yildiz A; Ozçelik GS; Sever N; Genc NM; Dokucu AI
    Int Urol Nephrol; 2014 Nov; 46(11):2057-61. PubMed ID: 24966099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The comparison of dextranomer/hyaluronic acid and polyacrylate-polyalcohol copolymers in endoscopic treatment of vesicoureteral reflux.
    Karakus SC; User İR; Kılıc BD; Akçaer V; Ceylan H; Ozokutan BH
    J Pediatr Surg; 2016 Sep; 51(9):1496-500. PubMed ID: 27061353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can distal ureteral diameter measurement predict primary vesicoureteral reflux clinical outcome and success of endoscopic injection?
    Payza AD; Hoşgör M; Serdaroğlu E; Sencan A
    J Pediatr Urol; 2019 Oct; 15(5):515.e1-515.e8. PubMed ID: 31420285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review & meta-analysis comparing outcomes of endoscopic treatment of primary vesico ureteric reflux in children with polyacrylate poly alcohol copolymer versus dextranomer hyaluranic acid.
    Babu R; Chandrasekharam VVS
    J Pediatr Surg; 2022 Nov; 57(11):683-689. PubMed ID: 35197197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic treatment of vesicoureteral reflux associated with paraureteral diverticula in children.
    Cerwinka WH; Scherz HC; Kirsch AJ
    J Urol; 2007 Oct; 178(4 Pt 1):1469-73. PubMed ID: 17706704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic treatment of vesicoureteral reflux with polyacrylate polyalcohol copolymer and dextranomer/hyaluronic acid in adults.
    Turk A; Selimoglu A; Demir K; Celik O; Saglam E; Tarhan F
    Int Braz J Urol; 2014; 40(3):379-83. PubMed ID: 25010304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study using a new bulking agent for the treatment of vesicoureteral reflux: polyacrylamide hydrogel.
    Cloutier J; Blais AS; Moore K; Bolduc S
    J Urol; 2013 Sep; 190(3):1034-7. PubMed ID: 23538241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ureteral Obstruction After Endoscopic Treatment of Vesicoureteral Reflux: Does the Type of Injected Bulking Agent Matter?
    Friedmacher F; Puri P
    Curr Urol Rep; 2019 Jul; 20(9):49. PubMed ID: 31289951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Learning from the learning curve: factors associated with successful endoscopic correction of vesicoureteral reflux using dextranomer/hyaluronic acid copolymer.
    Dave S; Lorenzo AJ; Khoury AE; Braga LH; Skeldon SJ; Suoub M; Farhat W; Pippi Salle JL; Bägli DJ
    J Urol; 2008 Oct; 180(4 Suppl):1594-9; discussion 1599-600. PubMed ID: 18710756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.